Natrium Chloratum Kabi (Sodium Chloride)

Sodium chloride, the active ingredient in Natrium Chloratum Kabi, is an electrolyte solution presented as an injectable preparation for intravenous, intramuscular, and subcutaneous use. It restores extracellular fluid volume and electrolyte balance by supplying sodium and chloride ions to patients requiring fluid replacement.

GNH USA supplies Natrium Chloratum Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability and regulatory compliance across multiple markets.

Sodium chloride is employed in clinical practice for fluid and electrolyte replacement across several conditions.

Dehydration: restores intravascular volume and corrects sodium and chloride deficits. Hypovolemia due to blood loss or surgery: supports circulatory stability by expanding extracellular fluid. Electrolyte imbalance (hyponatremia/hypochloremia): provides essential ions to normalize serum concentrations.

Sodium chloride injection may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort or tenderness at the injection site. - Phlebitis or thrombophlebitis: inflammation of the vein where the drug is administered. - Transient hypernatremia: temporary rise in serum sodium when given rapidly. - Mild rash or urticaria: skin redness or hives indicating a mild hypersensitivity.

Serious or Rare Side Effects: - Severe hypernatremia: marked elevation of sodium causing neurological impairment. - Fluid overload: excessive volume leading to pulmonary edema or heart strain. - Anaphylactic reaction: sudden, life‑threatening allergic response requiring emergency care. - Electrolyte disturbances: severe hyponatremia or chloride imbalance due to dosing errors.

When using sodium chloride injection, clinicians should observe several precautionary measures to ensure patient safety. - Assess fluid status: evaluate patient’s volume status before administration. - Monitor electrolytes: regularly check serum sodium and chloride concentrations. - Renal function: adjust usage in patients with impaired kidney function. - Cardiac status: use cautiously in heart failure or hypertension. - Pregnancy and lactation: consider use only when clearly indicated. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Sodium chloride may interact with other medications, influencing electrolyte balance or fluid status.

Major Interactions (Avoid): - Hypertonic saline solutions: concurrent use can cause dangerous hypernatremia. - Loop or thiazide diuretics: may exacerbate electrolyte shifts and volume depletion. - ACE inhibitors or ARBs: increased risk of hyperkalemia when combined with other electrolyte therapies.

Moderate Interactions (Monitor Closely): - Corticosteroids: monitor for sodium retention and fluid overload. - Vasopressors: may require dose adjustments due to altered intravascular volume. - Blood products: watch for cumulative electrolyte load and volume changes.